These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8530951)

  • 1. Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy.
    Bandmann O; Wenning GK; Quinn NP; Harding AE
    J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):557. PubMed ID: 8530951
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers.
    Panserat S; Mura C; Gérard N; Vincent-Viry M; Galteau MM; Jacqz-Aigrain E; Krishnamoorthy R
    Hum Genet; 1994 Oct; 94(4):401-6. PubMed ID: 7927337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphic CfoI site in exon 6 of the human cytochrome P450 CYP2D6 gene detected by the polymerase chain reaction.
    Armstrong M; Idle JR; Daly AK
    Hum Genet; 1993 Jul; 91(6):616-7. PubMed ID: 8340116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease.
    Tsuneoka Y; Matsuo Y; Iwahashi K; Takeuchi H; Ichikawa Y
    J Biochem; 1993 Aug; 114(2):263-6. PubMed ID: 7903297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy.
    Iwahashi K; Miyatake R; Tsuneoka Y; Matsuo Y; Ichikawa Y; Hosokawa K; Sato K; Hayabara T
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):263-4. PubMed ID: 7876880
    [No Abstract]   [Full Text] [Related]  

  • 6. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
    Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
    Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Parkinson's disease and polymorphism at the CYP2D6 locus.
    Mazzetti P; Le Guern E; Bonnet AM; Vidailhet M; Brice A; Agid Y
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):871-2. PubMed ID: 8021689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Genetic polymorphism of drug metabolizing enzymes].
    Yokoi T; Kamataki T
    Seikagaku; 1997 Oct; 69(10):1196-9. PubMed ID: 9431010
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.
    Landi MT; Ceroni M; Martignoni E; Bertazzi PA; Caporaso NE; Nappi G
    Adv Neurol; 1996; 69():61-72. PubMed ID: 8615186
    [No Abstract]   [Full Text] [Related]  

  • 10. "It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism.
    Kroemer HK; Eichelbaum M
    Life Sci; 1995; 56(26):2285-98. PubMed ID: 7791516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack association between schizophrenia and the CYP2D6 gene polymorphisms.
    Pirmohamed M; Wild MJ; Kitteringham NR; O'Brien K; Buchan IE; Back DJ; Park BK
    Am J Med Genet; 1996 Apr; 67(2):236-7. PubMed ID: 8723057
    [No Abstract]   [Full Text] [Related]  

  • 12. Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon.
    Evert B; Griese EU; Eichelbaum M
    Pharmacogenetics; 1994 Oct; 4(5):271-4. PubMed ID: 7894499
    [No Abstract]   [Full Text] [Related]  

  • 13. Poor metabolisers of nicotine and CYP2D6 polymorphism.
    Cholerton S; Arpanahi A; McCracken N; Boustead C; Taber H; Johnstone E; Leathart J; Daly AK; Idle JR
    Lancet; 1994 Jan; 343(8888):62-3. PubMed ID: 7905082
    [No Abstract]   [Full Text] [Related]  

  • 14. Dinucleotide repeat polymorphism at the human debrisoquine 4-hydroxylase (CYP2D) locus.
    Polymeropoulos MH; Rath DS; Xiao H; Merril CR
    Nucleic Acids Res; 1991 Apr; 19(8):1961. PubMed ID: 2030982
    [No Abstract]   [Full Text] [Related]  

  • 15. A BamHI polymorphism in the human cytochrome P450 gene, CYP2D6.
    Morimoto Y; Murayama N; Kuwano A; Yoshimura O; Kondo I
    Clin Genet; 1995 Feb; 47(2):103-4. PubMed ID: 7606840
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of debrisoquine hydroxylation phenotypes.
    Wolf CR; Moss JE; Miles JS; Gough AC; Spurr NK
    Lancet; 1990 Dec; 336(8728):1452-3. PubMed ID: 1978915
    [No Abstract]   [Full Text] [Related]  

  • 17. Dinucleotide repeat polymorphism at the debrisoquine 4-hydroxylase (CYP2D) locus.
    Trofatter JA; Gusella JF; Haines JL
    Nucleic Acids Res; 1991 May; 19(10):2802. PubMed ID: 2041763
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetics: Part II.
    Gibaldi M
    Ann Pharmacother; 1992 Feb; 26(2):255-61. PubMed ID: 1554942
    [No Abstract]   [Full Text] [Related]  

  • 19. Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.
    Broly F; Meyer UA
    Pharmacogenetics; 1993 Jun; 3(3):123-30. PubMed ID: 8101460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency.
    Broly F; Marez D; Lo Guidice JM; Sabbagh N; Legrand M; Boone P; Meyer UA
    Hum Genet; 1995 Nov; 96(5):601-3. PubMed ID: 8530011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.